These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26506433)

  • 21. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection.
    Ganusov VV; De Boer RJ
    PLoS Comput Biol; 2006 Mar; 2(3):e24. PubMed ID: 16604188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations.
    Batorsky R; Sergeev RA; Rouzine IM
    PLoS Comput Biol; 2014 Oct; 10(10):e1003878. PubMed ID: 25356981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy.
    Casazza JP; Betts MR; Hill BJ; Brenchley JM; Price DA; Douek DC; Koup RA
    J Virol; 2005 Mar; 79(6):3653-63. PubMed ID: 15731259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Control of HIV infection and selection/ accumulation of HIV escape mutants by HIV-specific cytotoxic T lymphocytes (CTLs)].
    Murakoshi H; Takiguchi M
    Uirusu; 2013; 63(2):209-18. PubMed ID: 25366055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of HIV-specific CD8
    Leitman EM; Thobakgale CF; Adland E; Ansari MA; Raghwani J; Prendergast AJ; Tudor-Williams G; Kiepiela P; Hemelaar J; Brener J; Tsai MH; Mori M; Riddell L; Luzzi G; Jooste P; Ndung'u T; Walker BD; Pybus OG; Kellam P; Naranbhai V; Matthews PC; Gall A; Goulder PJR
    J Exp Med; 2017 Nov; 214(11):3239-3261. PubMed ID: 28983013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.
    Ishii H; Kawada M; Tsukamoto T; Yamamoto H; Matsuoka S; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Naruse TK; Kimura A; Takiguchi M; Matano T
    J Virol; 2012 Jan; 86(2):738-45. PubMed ID: 22072784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs.
    Paul S; Piontkivska H
    BMC Microbiol; 2010 Aug; 10():212. PubMed ID: 20696039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational inference methods for selective sweeps arising in acute HIV infection.
    Leviyang S
    Genetics; 2013 Jul; 194(3):737-52. PubMed ID: 23666940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8
    Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
    Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
    Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
    EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection.
    Liu Y; Mullins JI; Mittler JE
    Virology; 2006 Mar; 347(1):140-6. PubMed ID: 16387340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constructing lower-bounds for CTL escape rates in early SIV infection.
    Leviyang S
    J Theor Biol; 2014 Jul; 352():82-91. PubMed ID: 24603063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.